CN116509946A - 一种治疗前列腺增生的中药复方及其制备方法 - Google Patents
一种治疗前列腺增生的中药复方及其制备方法 Download PDFInfo
- Publication number
- CN116509946A CN116509946A CN202310455265.XA CN202310455265A CN116509946A CN 116509946 A CN116509946 A CN 116509946A CN 202310455265 A CN202310455265 A CN 202310455265A CN 116509946 A CN116509946 A CN 116509946A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- root
- prostatic hyperplasia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 54
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 title claims abstract description 33
- 208000004403 Prostatic Hyperplasia Diseases 0.000 title claims abstract description 33
- 150000001875 compounds Chemical class 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims description 12
- 240000000249 Morus alba Species 0.000 claims abstract description 33
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 32
- 235000012222 talc Nutrition 0.000 claims abstract description 19
- 239000000454 talc Substances 0.000 claims abstract description 19
- 229910052623 talc Inorganic materials 0.000 claims abstract description 19
- 244000150195 Cyperus longus Species 0.000 claims abstract description 15
- 241001116757 Pyrrosia lingua Species 0.000 claims abstract description 15
- 241000173529 Aconitum napellus Species 0.000 claims abstract description 14
- 229940023019 aconite Drugs 0.000 claims abstract description 14
- 240000005528 Arctium lappa Species 0.000 claims abstract description 13
- 235000003130 Arctium lappa Nutrition 0.000 claims abstract description 13
- 235000003805 Musa ABB Group Nutrition 0.000 claims abstract description 13
- 241000972673 Phellodendron amurense Species 0.000 claims abstract description 13
- 235000015266 Plantago major Nutrition 0.000 claims abstract description 13
- 244000274050 Platycodon grandiflorum Species 0.000 claims abstract description 13
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 13
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 235000008078 Arctium minus Nutrition 0.000 claims abstract description 12
- 241000202726 Bupleurum Species 0.000 claims abstract description 12
- 241001571764 Lysimachia christinae Species 0.000 claims abstract description 12
- 241000951473 Schizonepeta Species 0.000 claims abstract description 12
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 9
- 235000018958 Gardenia augusta Nutrition 0.000 claims abstract description 7
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract 5
- 240000008790 Musa x paradisiaca Species 0.000 claims abstract 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 239000000284 extract Substances 0.000 claims description 17
- 239000012530 fluid Substances 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 12
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 9
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 6
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 6
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 229920000881 Modified starch Polymers 0.000 claims description 4
- 241000207929 Scutellaria Species 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 4
- 239000000945 filler Substances 0.000 claims description 4
- 239000000314 lubricant Substances 0.000 claims description 4
- 235000019359 magnesium stearate Nutrition 0.000 claims description 4
- 229920002101 Chitin Polymers 0.000 claims description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 3
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims description 3
- 239000002002 slurry Substances 0.000 claims description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 3
- 229920002785 Croscarmellose sodium Polymers 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 235000012239 silicon dioxide Nutrition 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 244000075634 Cyperus rotundus Species 0.000 abstract description 2
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 48
- 230000000694 effects Effects 0.000 description 29
- 210000004369 blood Anatomy 0.000 description 26
- 239000008280 blood Substances 0.000 description 26
- 208000002193 Pain Diseases 0.000 description 19
- 210000004185 liver Anatomy 0.000 description 17
- 206010011224 Cough Diseases 0.000 description 14
- 241000699670 Mus sp. Species 0.000 description 14
- 230000027939 micturition Effects 0.000 description 14
- 230000001717 pathogenic effect Effects 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 14
- 210000002700 urine Anatomy 0.000 description 14
- 230000001737 promoting effect Effects 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 13
- 206010037660 Pyrexia Diseases 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 12
- 238000001035 drying Methods 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 12
- 210000002307 prostate Anatomy 0.000 description 12
- 240000001972 Gardenia jasminoides Species 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 10
- 239000002398 materia medica Substances 0.000 description 10
- 208000011580 syndromic disease Diseases 0.000 description 10
- 210000003932 urinary bladder Anatomy 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 241000723347 Cinnamomum Species 0.000 description 8
- 206010013954 Dysphoria Diseases 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 241001127637 Plantago Species 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 238000010926 purge Methods 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 206010047700 Vomiting Diseases 0.000 description 7
- 230000000740 bleeding effect Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 235000013399 edible fruits Nutrition 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 230000008673 vomiting Effects 0.000 description 7
- 208000006673 asthma Diseases 0.000 description 6
- 230000001976 improved effect Effects 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 5
- 208000034507 Haematemesis Diseases 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 5
- 210000000582 semen Anatomy 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 4
- 206010014025 Ear swelling Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 208000037386 Typhoid Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 210000000813 small intestine Anatomy 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 201000008297 typhoid fever Diseases 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 210000005069 ears Anatomy 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 201000009240 nasopharyngitis Diseases 0.000 description 3
- 206010029446 nocturia Diseases 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000213015 Bupleurum scorzonerifolium Species 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 241001672694 Citrus reticulata Species 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241001499733 Plantago asiatica Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 244000299790 Rheum rhabarbarum Species 0.000 description 2
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 2
- 241001093501 Rutaceae Species 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 208000031975 Yang Deficiency Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940117173 croton oil Drugs 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- NQWVSMVXKMHKTF-JKSUJKDBSA-N (-)-Arctigenin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-JKSUJKDBSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241001671653 Aconitum carmichaelii Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- YYGRXNOXOVZIKE-UHFFFAOYSA-N Arctigenin Natural products COC1CCC(CC2COC(=O)C2CC3CCC(O)C(C3)OC)CC1OC YYGRXNOXOVZIKE-UHFFFAOYSA-N 0.000 description 1
- 241000208843 Arctium Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 235000004012 Calla palustris Nutrition 0.000 description 1
- 240000006620 Calla palustris Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 208000009084 Cold Injury Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000037740 Coptis chinensis Species 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 241001481833 Coryphaena hippurus Species 0.000 description 1
- 241000234646 Cyperaceae Species 0.000 description 1
- 235000016854 Cyperus rotundus Nutrition 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000522190 Desmodium Species 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 235000006487 Euryale ferox Nutrition 0.000 description 1
- 244000268590 Euryale ferox Species 0.000 description 1
- 206010016100 Faeces discoloured Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- OIFFJDGSLVHPCW-UHFFFAOYSA-N Guayarol Natural products COc1ccc(CC2C(Cc3ccc(O)c(O)c3)COC2=O)cc1OC OIFFJDGSLVHPCW-UHFFFAOYSA-N 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000004898 Herpes Labialis Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- NQWVSMVXKMHKTF-UHFFFAOYSA-N L-Arctigenin Natural products C1=C(OC)C(OC)=CC=C1CC1C(CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-UHFFFAOYSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241001596950 Larimichthys crocea Species 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010067152 Oral herpes Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241001079007 Phellodendron chinense Species 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 102000007066 Prostate-Specific Antigen Human genes 0.000 description 1
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 206010051482 Prostatomegaly Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000025505 Pyrrosia Species 0.000 description 1
- 241001237997 Pyrrosia petiolosa Species 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000951376 Schizonepeta tenuifolia Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042682 Swelling face Diseases 0.000 description 1
- PDMMFKSKQVNJMI-BLQWBTBKSA-N Testosterone propionate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CC)[C@@]1(C)CC2 PDMMFKSKQVNJMI-BLQWBTBKSA-N 0.000 description 1
- 241001627955 Tetraodon lineatus Species 0.000 description 1
- 206010046555 Urinary retention Diseases 0.000 description 1
- 208000028938 Urination disease Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- BPYGTFFYYOWDBC-LOVSFRALSA-N arctiin Natural products COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc3ccc(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c3)cc1OC BPYGTFFYYOWDBC-LOVSFRALSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000002595 cold damage Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- LXBIFEVIBLOUGU-JGWLITMVSA-N duvoglustat Chemical compound OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O LXBIFEVIBLOUGU-JGWLITMVSA-N 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000010396 fuzi Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000018997 giddiness Diseases 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229940095686 granule product Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- NWFYESYCEQICQP-UHFFFAOYSA-N methylmatairesinol Natural products C1=C(OC)C(OC)=CC=C1CC1C(=O)OCC1CC1=CC=C(O)C(OC)=C1 NWFYESYCEQICQP-UHFFFAOYSA-N 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000009999 singeing Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960001712 testosterone propionate Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗前列腺增生的中药复方,由下列中药原料提取制备而成:桑叶20‑30份、桑白皮15‑25份、地骨皮15‑20份、桔梗20‑30份、牛蒡子10‑20份、荆芥20‑30份、肉桂8‑12份、制附子5‑8份、柴胡15‑25份、香附5‑15份、陈皮20‑30份、车前子20‑30份、金钱草15‑25份、石韦20‑30份、栀子10‑20份、滑石8‑12份、黄芩15‑25份、黄柏10‑20份,并公开其制备方法,全方通过泄肺热,开肺气,达到肺肃降,通调水道,下输膀胱,通小便,达到治疗前列腺增生的目的。
Description
技术领域
本发明属于中医药技术领域,特别涉及一种治疗前列腺增生的中药复方及其制备方法。
背景技术
前列腺肥大亦称前列腺良性肥大或前列腺增生症,在中医学辨证属癃闭、淋症等范围。本病为中老年男姓的一种常见病,发病率随年龄增长而逐渐增加。目前认为其发病可能与老年人性激素平衡失调或胆固醇积聚有关,或泌尿系统的炎症和盆腔瘀血也可使症状加重。症状主要为尿频、排尿因难、急性尿闭或尿失禁,早期往往仅为夜尿次数增多。前列腺肥大,轻者并不引起尿路梗阻而发生小便障碍;重者,开始小便次数增多,以夜间为明显,随着小便排出困难,有尿意不尽之感,严重时要用力努挣才能排出,有时可致急性尿潴留。前列腺增生的中医中药治疗方法,中医认为疾病的发生与发展涉及肺肾脾三脏,又或与气虚血郁有关中医之肺为华盖,脾气失宣,则下调困难,正所谓上窍闭而下窍不通,而脾为后天之本,运化无权,则水处不通,引起癃闭。临床上认为湿重,湿热下注,至于清热利水,八正散加味,治疗可以选择车前子、滑石、山栀、灯芯草、甘石稍,毒壅盛致以清热,祛毒,泄肝火,用龙胆泻肝汤,但效果并不是太好。
发明内容
发明目的:为了解决上述问题,本发明的目的在于提供一种治疗前列腺增生的中药复方及制备方法和应用。
技术方案:本发明的目的是通过如下的方案实现的:
一种治疗前列腺增生的中药复方,由下列中药原料提取制备而成:桑叶20-30份、桑白皮15-25份、地骨皮15-20份、桔梗20-30份、牛蒡子10-20份、荆芥20-30份、肉桂8-12份、制附子5-8份、柴胡15-25份、香附5-15份、陈皮20-30份、车前子20-30份、金钱草15-25份、石韦20-30份、栀子10-20份、滑石8-12份、黄芩15-25份、黄柏10-20份。
所述一种治疗前列腺增生的中药复方,由下列中药原料提取制备而成:桑叶25份、桑白皮20份、地骨皮18份、桔梗25份、牛蒡子15份、荆芥25份、肉桂10份、制附子7份、柴胡20份、香附10份、陈皮25份、车前子25份、金钱草20份、石韦25份、栀子15份、滑石10份、黄芩20份、黄柏15份。
所述一种治疗前列腺增生的中药复方,由下列中药原料提取制备而成:桑叶20份、桑白皮25份、地骨皮15份、桔梗30份、牛蒡子10份、荆芥30份、肉桂8份、制附子8份、柴胡15份、香附15份、陈皮20份、车前子30份、金钱草15份、石韦30份、栀子10份、滑石12份、黄芩15份、黄柏20份。
所述一种治疗前列腺增生的中药复方,由下列中药原料提取制备而成:桑叶30份、桑白皮15份、地骨皮20份、桔梗20份、牛蒡子20份、荆芥20份、肉桂12份、制附子5份、柴胡25份、香附5份、陈皮30份、车前子20份、金钱草25份、石韦20份、栀子20份、滑石8份、黄芩25份、黄柏10份。
所述一种治疗前列腺增生的中药复方,制备方法为:
(1)提取:取滑石先煎1小时,再加入其他原料,加水浸泡1小时后煎煮2次,每次1.5小时,第一次煎煮加入10倍药材量水,第二次煎煮加入8倍药材量水,煎煮液均经100目筛过滤,合并两次煎煮液;
(2)浓缩:取步骤(1)合并后煎煮液,浓缩,真空度为-0.05~-0.10Mpa,温度为60~80℃,控制浓缩后清膏相对密度为1.10~1.20;
(3)醇沉:取步骤(2)的清膏,加入95%乙醇,搅匀,使药液含醇量达到70%,静置24小时;
(4)回收乙醇:取步骤(3)静置后的上清液,回收乙醇后浓缩至相对密度在50℃测为1.15~1.20的清膏;
(5)制备干膏粉:取步骤(4)的清膏,喷雾干燥,粉碎成干膏粉,添加辅料,制备成固体制剂。
所述一种治疗前列腺增生的中药复方,制备方法中辅料包括填充剂、崩解剂、润滑剂、粘合剂,填充剂包括:淀粉、预胶化淀粉、甘露醇、甲壳素、微晶纤维素、蔗糖中的一种或多种;崩解剂包括:淀粉、预胶化淀粉、微晶纤维素、羧甲基纤维素钠、交联聚乙烯吡咯烷酮、低取代羟丙纤维素、交联羧甲基纤维素钠中的一种或多种;润滑剂包括:硬脂酸镁、十二烷基硫酸钠、滑石粉、二氧化硅中的一种或多种;粘合剂包括:淀粉浆、聚乙烯吡咯烷酮、羟丙基甲基纤维素中的一种或多种。
所述一种治疗前列腺增生的中药复方,所述前列腺增生属于肺热气壅型。
桑叶是桑科植物桑的干燥叶,又名家桑、荆桑、桑椹树、黄桑叶等,全国大部分地区多有生产,桑叶提取物脱氧野尻霉素与葛根提取类黄酮物质结合形成一种新物质-洗胰清糖素,适合用于治降血糖、血脂、抗炎等作用。性味苦、甘,性寒。归肺、肝经。疏散风热,清肺润燥,平肝明目,凉血止血。用于风热感冒,温病初起,肺热咳嗽,肝阳上亢眩晕,目赤昏花,血热妄行之咳血、吐血。
桑白皮为双子叶植物桑科桑除去栓皮后的干燥根皮,始载于《神农本草经》,其性味甘寒,归肺脾经,桑白皮具有泻肺平喘,行水消肿的功效,主治肺热喘咳、尿少水肿、面目肌肤肿胀等症。桑白皮具有降压、抗炎等多种现代药理活性。功用主要包括:泻肺平喘、利水消肿、补虚、活血祛瘀、化痰止嗽、止血、生津止渴、泻下通便、驱虫、消食、祛风、通淋、止痛等。
地骨皮别名枸杞皮,为茄科、枸杞属植物,是枸杞Lycium chinense Mill.的根皮。可入药,具有退热除蒸之效,凉血除蒸、清肺降火等功效。《本草述》:"主治虚劳发热,往来寒热,诸见血证,鼻衄,咳嗽血,咳嗽、喘,消瘅,中风,眩晕,痉痼,腰痛,行痹,脚气,水肿,虚烦,悸,健忘,小便不通,赤白浊。"
桔梗为桔梗科植物桔梗Platycodon grandiflorus(Jacq.)A.Dc.的干燥根。春、秋二季采挖,洗净,除去须根,趁鲜剥去外皮或不去外皮,干燥。生于山地草坡、林缘或有栽培。分布于全国各地区。具有宣肺,利咽,祛痰,排脓的功效。用于咳嗽痰多,胸闷不畅,咽痛音哑,肺痈吐脓。
牛蒡子为菊科二年生草本植物牛蒡的干燥成熟果实。呈长倒卵形,略扁,微弯曲,长5~7mm,宽2~3mm。表面灰褐色,带紫黑色斑点,有数条纵棱,通常中间1~2条较明显。顶端钝圆,稍宽,顶面有圆环,中间具点状花柱残迹;基部略窄,着生面色较淡。果皮较硬,子叶2,淡黄白色,富油性。无臭,味苦后微辛而稍麻舌。秋季果实成熟时采收果序,晒干,打下果实,除去杂质,再晒干。生用或炒用,用时捣碎。具有疏散风热,宣肺透疹,利咽散结,解毒消肿之功效。属于解表药中发散风热药。现代研究,牛蒡子还可用于防治糖尿病肾病,牛蒡果实含牛蒡甙经水解生成的牛蒡甙元具有抗癌活性。
荆芥为唇形科植物荆芥Schizonepeta tenuifolia Briq.的干燥地上部分。夏、秋二季花开到顶、穗绿时采割,除去杂质,晒干。味辛,性微温。归肺、肝经。解表散风,透疹,消疮。用于感冒,头痛,麻疹,风疹,疮疡初起。《本草纲目》:散风热,清头目。作枕,去头项风;同石膏末服,去风热头痛。《本经逢原》:产后止血,童便制黑用。凡食河豚及一切无鳞鱼与驴肉俱忌之;食黄鱼后服之,令人吐血,惟地浆可解。与蟹同食动风。《本草从新》:能发汗。散风湿。利咽喉。清头目。治伤寒头痛。中风口噤。身强项直。
制附子为毛茛科植物乌头Aconitum carmichaeli Debx.的子根的加工品。6月下旬至8月上旬采挖,除去母根、须根及泥沙,习称“泥附子”,经盐渍、水漂、煮、炒等法炮制后降低毒性,称“制附子”。辛、甘,大热;有毒。归心、肾、脾经。回阳救逆,补火助阳,逐风寒湿邪。用于亡阳虚脱,肢冷脉微,阳痿,宫冷,心腹冷痛,虚寒吐泻,阴寒水肿,阳虚外感,寒湿痹痛。
肉桂为樟科植物肉桂Cinnamomum cassia Presl的干燥树皮。多于秋季剥取,阴干。味辛、甘,性大热。归肾、脾、心、肝经。有补火助阳,引火归元,散寒止痛,温通经脉的功效。用于阳痿宫冷,腰膝冷痛,肾虚作喘,虚阳上浮,眩晕目赤,心腹冷痛,虚寒吐泻,寒疝腹痛,痛经经闭。
柴胡为伞形科植物柴胡或狭叶柴胡的干燥根。春、秋二季采挖,除去茎叶及泥沙,干燥。柴胡是常用解表药。别名地熏、山菜、菇草、柴草,性味苦、微寒,归肝、胆经。有和解表里,疏肝升阳之功效。用于感冒发热、寒热往来、疟疾、肝郁气滞、胸肋胀痛、脱肛、子宫脱垂、月经不调。《滇南本草》:“伤寒发汗用柴胡,至四日后方可用:若用在先,阳症引入阴经,当忌用。”《本经逢原》:“柴胡,小儿五疳羸热,诸疟寒热,咸宜用之。痘疹见点后有寒热,或胁下疼热,于透表药内用之,不使热留少阳经中,则将来无咬牙之患。”
香附为莎草科植物莎草的干燥根茎。秋季采挖,燎去毛须,置沸水中略煮或蒸透后晒干,或燎后直接晒干。辛、微苦、微甘,平。归肝、脾、三焦经。疏肝解郁,理气宽中,调经止痛。用于肝郁气滞,胸胁胀痛,疝气疼痛,乳房胀痛,脾胃气滞,脘腹痞闷,胀满疼痛,月经不调,经闭痛经。《本草衍义补遗》:香附子,必用童便浸,凡血气药必用之,引至气分而生血,此阳生阴长之义也。朱震亨:香附,《本草》不言补,而方家言于老人有益,意有存焉,盖于行中有补理。
陈皮为芸香科植物橘(Citrus reticulata Blanco)及其栽培变种的干燥成熟果皮。药材分为“陈皮”和“广陈皮”。采摘成熟果实,剥取果皮,晒干或低温干燥。味苦、辛,性温。归肺、脾经。理气健脾,燥湿化痰。用于脘腹胀满,食少吐泻,咳嗽痰多。《名医别录》:下气,止呕。《本草纲目》:疗呕哕反胃嘈杂,时吐清水。
车前子为车前科植物车前Plantago asiatica L.或平车前PlantagodepressaWilld.的干燥成熟种子。夏、秋二季种子成熟时采收果穗,晒干,搓出种子,除去杂质。味甘,性寒。归肝、肾、肺、小肠经。清热利尿通淋,渗湿止泻,明目,祛痰。用于热淋涩痛,水肿胀满,暑湿泄泻,目赤肿痛,痰热咳嗽。
金钱草为报春花科植物过路黄Lysimachia christinae Hance的干燥全草。分布于云南、四川、贵州、陕西(南部)、河南、湖北、湖南、广西、广东、江西、安徽、江苏、浙江、福建等地。具有利湿退黄,利尿通淋,解毒消肿之功效。常用于湿热黄疸,胆胀胁痛,石淋,热淋,小便涩痛,痈肿疔疮,蛇虫咬伤。
石韦为水龙骨科植物庐山石韦Pyrrosio,sheareri(Bak.)Ching、石韦Pyrrosialingua(Thunb.)Farwell或有柄石韦Pyrrosia petiolosa(Christ)Ching的干燥叶。全年均可采收,除去根茎和根,晒干或阴干。味甘、苦,性微寒。归肺、膀胱经。有利尿通淋,清肺止咳,凉血止血的功效。用于热淋,血淋,石淋,小便不通,淋沥涩痛,肺热喘咳,吐血,衄血,尿血,崩漏。《神农本草经》:劳热邪气,五癃闭不通,利小便水道。《本草纲目》:主崩漏金疮,清肺气。
栀子是茜草科植物栀子的果实。栀子的果实是传统中药,属卫生部颁布的第l批药食两用资源,具有护肝、利胆、降压、镇静、止血、消肿等作用。在中医临床常用于治疗黄疸型肝炎、扭挫伤、高血压、糖尿病等症。苦,寒。归心、肺、三焦经。泻火除烦,清热利湿,凉血解毒;外用消肿止痛。用于热病心烦,湿热黄疸,淋证涩痛,血热吐衄,目赤肿痛,火毒疮疡,外治扭挫伤痛。《本草衍义》:“仲景治(伤寒)发汗吐下后,虚烦不得眠;若剧者,必反复颠倒,心中懊憹,栀子豉汤治之。虚故不用大黄,有寒毒故也。栀子虽寒无毒,治胃中热气,既亡血、亡津液,腑脏无润养,内生虚热,非此物不可去。又治心经留热,小便亦涩,用去皮山栀子、火煨大黄、连翘、甘草(炙),等分,末之,水煎三钱服,无不利也。”《汤液本草》:“或用栀子利小便,实非利小便,清肺也,肺气清而化,膀胱为津液之府,小便得此气化而出也。栀子豉汤治烦躁,烦者气也,躁者血也,气主肺,血主肾,故用栀子以治肺烦,用香豉以治肾躁。躁者,懊憹不得眠也。”《本草经疏》:“栀子,清少阴之热,则五内邪气自去,胃中热气亦除。面赤酒疱齄鼻者,肺热之候也,肺主清肃,酒热客之,即见是证,于开窍之所延及于面也,肺得苦寒之气,则酒热自除而面鼻赤色皆退矣。其主赤白癞疮疡者,即诸痛痒疮疡皆属心火之谓。疗目赤热痛,及胸、心、大小肠大热,心中烦闷者,总除心、肺二经之火热也。此药味苦气寒,泻一切有余之火,故能主如上诸证。”“栀子禀至苦大寒之气,苦寒损胃而伤血,凡脾胃虚弱者忌之,血虚发热者忌之。性能泻有余之火,心肺无邪热者不宜用;小便不通,由于膀胱虚无气以化,而非热结小肠者不宜用;疮疡因气血虚,不能收敛,则为久冷败疮,非温暖补益之剂则不愈,此所谓既溃之后,一毫寒药不可用是也。世人又以治诸血证,不知血得热则行,得寒则凝,瘀血凝结于中,则反致寒热,或发热劳嗽,饮食减少,为难疗之病,凡治吐血法,当以顺气为先,盖血随气而行,气降则火降,火降则血自归经。不求其止而止矣。此治疗之要法,不可违也。”《本草崇原》:“言栀子生用则吐,炒黑则不吐,且以栀子豉汤为吐剂,愚每用生栀子及栀子豉汤,并未曾吐。
滑石具有利尿通淋,清热解暑,收湿敛疮的功效。本品有吸附和收敛作用,内服能保护肠壁。滑石粉撒布创面形成被膜,有保护创面,吸收分泌物,促进结痂的作用。
黄芩是唇形科黄芩属多年生草本植物;肉质根茎肥厚,叶坚纸质,披针形至线状披针形,总状花序在茎及枝上顶生,花冠紫、紫红至蓝色,花丝扁平,花柱细长,花盘环状,子房褐色,小坚果卵球形,花果期7~9月。黄芩生于向阳草坡地上,海拔60~1300(1700~2000)米。产于黑龙江,辽宁,内蒙古,河北,河南,甘肃,陕西,山西,山东,四川等地,中国北方多数省区都可种植。其以根入药,味苦、性寒,有清热燥湿、泻火解毒、止血、安胎等功效。主治温热病、上呼吸道感染、肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、胎动不安、高血压、痈肿疖疮等症。黄芩的临床抗菌性比黄连好,而且不产生抗药性。《本草纲目》:治风热湿热头疼,奔豚热痛,火咳肺痿喉腥,诸失血。《别录》:疗痰热胃中热,小腹绞痛,消谷,利小肠,女子血闭,淋露下血,小儿腹痛。《本经》:诸热黄胆,肠泄痢,逐水,下血闭,恶疮疽蚀火疡。《本经逢原》:苦寒,无毒。中空者为枯芩入肺,细实者为子芩入大肠,并煮熟酒炒用。
黄柏为芸香科植物黄皮树Phellodendron chinense Schneid.的干燥树皮。习称“川黄柏”。剥取树皮后,除去粗皮,晒干。味苦,性寒。归肾、膀胱经。有清热燥湿,泻火除蒸,解毒疗疮的功效。用于湿热泻痢,黄疸尿赤,带下阴痒,热淋涩痛,脚气痿蹙,骨蒸劳热,盗汗,遗精,疮疡肿毒,湿疹湿疮。盐黄柏滋阴降火。用于阴虚火旺,盗汗骨蒸。《伤寒论》:黄柏、栀子、甘草。治伤寒身黄发热。《傅青主女科》:黄柏、山药、车前子、芡实、白果。治下焦湿热,白浊带下。
中医配伍理论分析:前列腺增生的发生,与肺、脾、肝、肾、三焦、脏腑功能失调密切相关。上焦之气不化,当责之于肺,肺失清肃,则不能通调水道下输膀胱。中焦之气不化,当责之于脾,脾失健运,则不能升清降浊。下焦之气不化,当责之于肾,肾阳亏虚,气不化水;肾阴不足,阴不化阳。加之肝郁气滞,三焦气化不利,以及尿路阻塞,均可导致膀胱气化失常。而湿、热、瘀、滞、虚,又为癃闭主要病理因素。一般说来,本病初期为癃,若病程经久,正气衰败或邪实壅盛,可由癃至闭。临床多见虚实夹杂之证。
清代李用粹指出:一身之气关于肺,肺清则气行,肺浊则气壅,故小便不通,由肺气不能宣布者居多,宜清金降气为主,并参他症治之。肺为水之上源,热壅于肺,肺气不能肃降,津液输布失常,水道通调不利,不能下输膀胱,则小便不通;若热气太盛,肺热下移膀胱,膀胱因肺失清肃而不利,以致上、下焦均为热气闭阻,小便全无,则其病势迫急,证情重笃,较之前者更甚。本发明以桑叶、桑白皮、地骨皮,清泄肺热,滋养肺阴;桔梗、牛蒡子、荆芥开宣肺气,提壶揭盖,共为君药;肉桂、附子温补肾阳、鼓舞肾气,为臣药;柴胡、香附、陈皮疏肝理气;车前子、金钱草、石韦通利水道,共为佐药;栀子、滑石、黄芩、黄柏,清三焦湿热,为使药,由于肺中伏热,不能生水,或肺燥不能生水,全方通过泄肺热,开肺气,达到肺肃降,通调水道,下输膀胱,通小便,达到治疗前列腺增生的目的。
具体实施方式
实施例1:
取桑叶25g、桑白皮20g、地骨皮18g、桔梗25g、牛蒡子15g、荆芥25g、肉桂10g、制附子7g、柴胡20g、香附10g、陈皮25g、车前子25g、金钱草20g、石韦25g、栀子15g、滑石10g、黄芩20g、黄柏15g,制备方法为:
(1)提取:取滑石先煎1小时,再加入其他原料,加水浸泡1小时后煎煮2次,每次1.5小时,第一次煎煮加入10倍药材量水,第二次煎煮加入8倍药材量水,煎煮液均经100目筛过滤,合并两次煎煮液;
(2)浓缩:取步骤(1)合并后煎煮液,浓缩,真空度为-0.05~-0.10Mpa,温度为60~80℃,控制浓缩后清膏相对密度为1.10~1.20;
(3)醇沉:取步骤(2)的清膏,加入95%乙醇,搅匀,使药液含醇量达到70%,静置24小时;
(4)回收乙醇:取步骤(3)静置后的上清液,回收乙醇后浓缩至相对密度在50℃测为1.15~1.20的清膏;
(5)制备干膏粉:取步骤(4)的清膏,喷雾干燥,粉碎成干膏粉,添加淀粉、羧甲基纤维素钠、使用聚乙烯吡咯烷酮制粒,添加十二烷基硫酸钠,制备颗粒剂。
实施例2:
取桑叶20g、桑白皮25g、地骨皮15g、桔梗30g、牛蒡子10g、荆芥30g、肉桂8g、制附子8g、柴胡15g、香附15g、陈皮20g、车前子30g、金钱草15g、石韦30g、栀子10g、滑石12g、黄芩15g、黄柏20g,制备方法为:
(1)提取:取滑石先煎1小时,再加入其他原料,加水浸泡1小时后煎煮2次,每次1.5小时,第一次煎煮加入10倍药材量水,第二次煎煮加入8倍药材量水,煎煮液均经100目筛过滤,合并两次煎煮液;
(2)浓缩:取步骤(1)合并后煎煮液,浓缩,真空度为-0.05~-0.10Mpa,温度为60~80℃,控制浓缩后清膏相对密度为1.10~1.20;
(3)醇沉:取步骤(2)的清膏,加入95%乙醇,搅匀,使药液含醇量达到70%,静置24小时;
(4)回收乙醇:取步骤(3)静置后的上清液,回收乙醇后浓缩至相对密度在50℃测为1.15~1.20的清膏;
(5)制备干膏粉:取步骤(4)的清膏,喷雾干燥,粉碎成干膏粉,添加微晶纤维素、交联聚乙烯吡咯烷酮、使用淀粉浆制粒,添加硬脂酸镁,压片。
实施例3:
取桑叶30g、桑白皮15g、地骨皮20g、桔梗20g、牛蒡子20g、荆芥20g、肉桂12g、制附子5g、柴胡25g、香附5g、陈皮30g、车前子20g、金钱草25g、石韦20g、栀子20g、滑石8g、黄芩25g、黄柏10g,制备方法为:
(1)提取:取滑石先煎1小时,再加入其他原料,加水浸泡1小时后煎煮2次,每次1.5小时,第一次煎煮加入10倍药材量水,第二次煎煮加入8倍药材量水,煎煮液均经100目筛过滤,合并两次煎煮液;
(2)浓缩:取步骤(1)合并后煎煮液,浓缩,真空度为-0.05~-0.10Mpa,温度为60~80℃,控制浓缩后清膏相对密度为1.10~1.20;
(3)醇沉:取步骤(2)的清膏,加入95%乙醇,搅匀,使药液含醇量达到70%,静置24小时;
(4)回收乙醇:取步骤(3)静置后的上清液,回收乙醇后浓缩至相对密度在50℃测为1.15~1.20的清膏;
(5)制备干膏粉:取步骤(4)的清膏,喷雾干燥,粉碎成干膏粉,添加甲壳素、低取代羟丙纤维素、使用羟丙基甲基纤维素制粒,添加硬脂酸镁,灌胶囊。
实施例4:本发明对小鼠实验性前列腺增生的影响
取雄性小鼠80只,随机分为模型组、空白对照组、阳性药组[前列康(普乐安片,批准文号:国药准字Z33020303生产企业:浙江康恩贝制药股份有限公司)0.57g/kg组]、本发明实施例1颗粒剂产品2.5g/kg组,除空白对照组外其余各鼠每天皮下注射(Sc)1次丙酸睾丸酮(5mg/kg),1h后分别灌胃(ig)给药1次,空白组和模型组给予同体积的蒸馏水,连续30天,第31天处死小鼠,仔细剥离各鼠前列腺,分别称重(mg),计算前列腺指数(前列腺重量(mg/10g体重)。结果见表1。
表1本发明对实验性小鼠前列腺增生的影响(X±S)
组别 | 前列腺重(mg) | 前列腺指数(mg/10g) |
空白组 | 14.35±3.19 | 5.04±0.45 |
模型组 | 25.78±5.84△△ | 8.45±2.97△△ |
阳性药组 | 17.46±3.69** | 5.94±2.13** |
实施例1组 | 16.74±4.13** | 4.87±2.04** |
注:△△表示与空白对照组比较P<0.01,**表示与模型组比较P<0.01。
由表1可见,本发明与阳性药组(前列康组)均能明显抑制小鼠实验性前列腺增生,实施例1组效果好于阳性药组(前列康组)。
实施例5:本发明对小鼠耳肿胀的影响研究
取26-30g雄性小鼠,随机分为三组,每组10只,分别为即为实施例2组(20g/kg),阳性药前列康组(2g/kg)、生理盐水组(20ml/kg),灌胃给药,每天1次,连续给3天,末次给药30min后,用2%巴豆油0.05ml涂于小鼠左耳两侧,4h后脱椎处死,剪下左右耳。然后用打孔器(直径为9mm)分别在同一部位取下圆耳片,扭力天平称重,计算耳壳重量,结果见表2。
表2本发明对巴豆油所致小鼠耳肿胀的影响(X±S)
组别 | 数量 | 耳肿胀度(mg) |
生理盐水组 | 10 | 11.9±4.2 |
前列康组 | 10 | 9.3±2.8* |
实施例2组 | 10 | 7.5±3.4* |
*P<0.05**P<0.01与生理盐水组比较
实验结果表明,本发明实施例2组能减轻巴豆油所致的小鼠耳肿胀,与生理盐水组比较具有显著性差异(P<0.05),提示本发明具有明显的抗炎作用,效果好于阳性药组(前列康组)。
实施例6:本发明对肺热气壅型前列腺增生的临床试验资料
实验对象的一般资料:采用本发明中药组合物共治疗肺热气壅型前列腺增生100例,均为盐城市中医院病例,年龄最大者53岁,年龄最小者28岁,全部为男性。
诊断标准:1、通过彩超检查观察前列腺尺寸,大于3cm可诊断为前列腺增生;达到4-5cm可诊断为中、重度前列腺增生;2、通过直肠指检检查前列腺大小、前列腺两侧是否出现增生、中央沟是否消失,以此判断前列腺是否增生;3、结合前列腺特异抗原含量高低以及核磁共振扫描结果,与前列腺炎、前列腺癌相区别。中医诊断主要表现为小便涓滴不通,或点滴不爽,咽干,烦渴欲饮,呼吸短促,或有咳嗽。舌苔薄黄,脉数,属于肺热气壅型前列腺增生。
疗效标准:痊愈:排尿困难症状消失,直肠指检或B超提示肥大之前列腺恢复正常,同时中医症状好转。显效:排尿困难症状基本消失,夜尿次数减半或减少至2次以下。肛指或B超检查,肿大的前列腺缩小一级,残余尿减半,或减少到30毫升以下,同时中医症状好转。好转:排尿困难有不同程度的减轻,夜尿减少2次,但前列腺无明显改善,同时中医症状好转。无效:临床症状无好转,客观检查指标无改善。
治疗方法:用法用量:本发明实施例1所制备的颗粒剂,其用法与用量为每次2包,每包10克,每日3次,温水送服,一个周为一疗程,共治疗4疗程,结果见表3。
表3各组疗效的统计结果
疗效 | 痊愈 | 显效 | 好转 | 无效 | 总有效率 |
56 | 20 | 16 | 8 | 92% |
综上所述,本发明中药组合物泄肺热,开肺气,达到肺肃降,通调水道,下输膀胱,通小便,达到治疗前列腺增生的目的,对治疗肺热气壅型前列腺增生有显著的效果,患者易于接受。
下面结合具体实施方式,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。此外应理解,在阅读了本发明记载的内容之后,本领域技术人员可以对本发明作各种改动或修改,但这些等价形式同样落于本申请所附权利要求书所限定的范围。
Claims (7)
1.一种治疗前列腺增生的中药复方,其特征在于,由下列中药原料提取制备而成:桑叶20-30份、桑白皮15-25份、地骨皮15-20份、桔梗20-30份、牛蒡子10-20份、荆芥20-30份、肉桂8-12份、制附子5-8份、柴胡15-25份、香附5-15份、陈皮20-30份、车前子20-30份、金钱草15-25份、石韦20-30份、栀子10-20份、滑石8-12份、黄芩15-25份、黄柏10-20份。
2.如权利要求1所述一种治疗前列腺增生的中药复方,其特征在于,由下列中药原料提取制备而成:桑叶25份、桑白皮20份、地骨皮18份、桔梗25份、牛蒡子15份、荆芥25份、肉桂10份、制附子7份、柴胡20份、香附10份、陈皮25份、车前子25份、金钱草20份、石韦25份、栀子15份、滑石10份、黄芩20份、黄柏15份。
3.如权利要求1所述一种治疗前列腺增生的中药复方,其特征在于,由下列中药原料提取制备而成:桑叶20份、桑白皮25份、地骨皮15份、桔梗30份、牛蒡子10份、荆芥30份、肉桂8份、制附子8份、柴胡15份、香附15份、陈皮20份、车前子30份、金钱草15份、石韦30份、栀子10份、滑石12份、黄芩15份、黄柏20份。
4.如权利要求1所述一种治疗前列腺增生的中药复方,其特征在于,由下列中药原料提取制备而成:桑叶30份、桑白皮15份、地骨皮20份、桔梗20份、牛蒡子20份、荆芥20份、肉桂12份、制附子5份、柴胡25份、香附5份、陈皮30份、车前子20份、金钱草25份、石韦20份、栀子20份、滑石8份、黄芩25份、黄柏10份。
5.如权利要求1所述一种治疗前列腺增生的中药复方,其特征在于,制备方法为:
(1)提取:取滑石先煎1小时,再加入其他原料,加水浸泡1小时后煎煮2次,每次1.5小时,第一次煎煮加入10倍药材量水,第二次煎煮加入8倍药材量水,煎煮液均经100目筛过滤,合并两次煎煮液;
(2)浓缩:取步骤(1)合并后煎煮液,浓缩,真空度为-0.05~-0.10Mpa,温度为60~80℃,控制浓缩后清膏相对密度为1.10~1.20;
(3)醇沉:取步骤(2)的清膏,加入95%乙醇,搅匀,使药液含醇量达到70%,静置24小时;
(4)回收乙醇:取步骤(3)静置后的上清液,回收乙醇后浓缩至相对密度在50℃测为1.15~1.20的清膏;
(5)制备干膏粉:取步骤(4)的清膏,喷雾干燥,粉碎成干膏粉,添加辅料,制备成固体制剂。
6.如权利要求5所述一种治疗前列腺增生的中药复方,其特征在于,制备方法中辅料包括填充剂、崩解剂、润滑剂、粘合剂,填充剂包括:淀粉、预胶化淀粉、甘露醇、甲壳素、微晶纤维素、蔗糖中的一种或多种;崩解剂包括:淀粉、预胶化淀粉、微晶纤维素、羧甲基纤维素钠、交联聚乙烯吡咯烷酮、低取代羟丙纤维素、交联羧甲基纤维素钠中的一种或多种;润滑剂包括:硬脂酸镁、十二烷基硫酸钠、滑石粉、二氧化硅中的一种或多种;粘合剂包括:淀粉浆、聚乙烯吡咯烷酮、羟丙基甲基纤维素中的一种或多种。
7.如权利要求1所述一种治疗前列腺增生的中药复方,其特征在于,所述前列腺增生属于肺热气壅型。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310455265.XA CN116509946A (zh) | 2023-04-25 | 2023-04-25 | 一种治疗前列腺增生的中药复方及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310455265.XA CN116509946A (zh) | 2023-04-25 | 2023-04-25 | 一种治疗前列腺增生的中药复方及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116509946A true CN116509946A (zh) | 2023-08-01 |
Family
ID=87395298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310455265.XA Pending CN116509946A (zh) | 2023-04-25 | 2023-04-25 | 一种治疗前列腺增生的中药复方及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116509946A (zh) |
-
2023
- 2023-04-25 CN CN202310455265.XA patent/CN116509946A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111544543A (zh) | 一种具有清肺、解烟毒及解酒益肝功能的组合物 | |
CN113786459A (zh) | 一种用于心脑血管疾病的药物组合物及其制备方法与用途 | |
CN104758406A (zh) | 一种用于治疗子宫内膜炎的中药 | |
CN114099626A (zh) | 一种用于人体保健的多功能组合物及其制备方法与用途 | |
CN116509946A (zh) | 一种治疗前列腺增生的中药复方及其制备方法 | |
CN113812614A (zh) | 一种抗尿酸功能性食品 | |
CN102755519B (zh) | 葛根葛花抗口腔溃疡颗粒及其制备方法 | |
CN104958545A (zh) | 一种治疗产后缺乳的中药制剂及其制备方法 | |
CN104474430A (zh) | 一种治疗肝肾阴虚型霉菌性阴道炎的中药及制备方法 | |
CN104740483A (zh) | 一种用于治疗复发性口腔溃疡的中药 | |
CN109646665A (zh) | 杜仲清肺抗癌固体茶及其制备方法 | |
CN108714167B (zh) | 一种治疗白癜风的中药外用制剂及其制备方法 | |
CN114712470B (zh) | 一种治疗男士肾亏的药物及其制备方法 | |
CN108704040B (zh) | 一种中药组合物及其应用 | |
CN106139105A (zh) | 一种治疗尿毒症的中药配方 | |
CN105055784A (zh) | 治疗乳腺癌的中药 | |
CN107335018B (zh) | 一种用于老年病患者脾肾两虚兼夹血瘀的调补药物及其制备方法 | |
CN118161586A (zh) | 一种有助于消化功能的组合物及其制备方法 | |
CN105412673A (zh) | 一种治疗桥本氏病的药物及其制备方法 | |
CN104815136A (zh) | 一种用于治疗男子不育症的中药 | |
CN105194563B (zh) | 一种用于前列腺疾病的组合药剂及其制备方法 | |
CN105288166A (zh) | 一种用于甲状腺肿大的中药组合物及其制备方法 | |
CN114344434A (zh) | 一种治疗肺结节的中药组合物及其制备方法 | |
CN104288576A (zh) | 治疗白头叶猴呼吸系统疾病的中药制剂及其生产方法 | |
CN102988809B (zh) | 一种治疗尿路感染的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |